Osama Abdelghany

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Journal of Clinical Oncology · 2018 · 509 citations · Full text

Randomized Phase II Trial of Carboplatin–Paclitaxel Compared with Carboplatin–Paclitaxel–Trastuzumab in Advanced (Stage III–IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis

Amanda N. Fader, Dana M. Roque, Eric R. Siegel et al. · Clinical Cancer Research · 2020 · 292 citations · Full text

Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients

Chiang‐Shan R. Li, Peter Morgan, David Matuskey et al. · Proceedings of the National Academy of Sciences · 2010 · 95 citations

Mfc Activation, Inhibitory Process, Psychopharmacology +22

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab

Hannah Dzimitrowicz, Michael Berger, Craig Vargo et al. · Journal of Clinical Oncology · 2016 · 82 citations · Full text

Breast Oncology, Tumor Response Rate, Immunology +19

The effects of methylphenidate on resting-state striatal, thalamic and global functional connectivity in healthy adults

Olivia M. Farr, Sheng Zhang, Sien Hu et al. · The International Journal of Neuropsychopharmacology · 2014 · 59 citations · Full text